Irreversible binding of [3H] (−) N-chloroethylnorapomorphine to mammalian brain tissue
- 1 August 1983
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 33 (8), 769-778
- https://doi.org/10.1016/0024-3205(83)90783-x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- The effects of (−)N-(chloroethyl)-norapomorphine on [3H]-apomorphine binding to striatal dopamine receptorsBiochemical Pharmacology, 1982
- Irreversible blockade of striatal dopamine receptors in vivo by a derivative of α-flupenthixolEuropean Journal of Pharmacology, 1982
- Dopamine autoreceptors differ pharmacologically from postsynaptic dopamine receptors: Effects of (−)-N-(2-chloroethyl)-norapomorphineEuropean Journal of Pharmacology, 1982
- Pharmacology of [3H]apomorphine binding to bovine brain tissueBiochemical Pharmacology, 1981
- Aporphines. 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphinesJournal of Medicinal Chemistry, 1981
- Chloroethylnorapomorphine, a proposed long-acting dopamine antagonist: Interactions with dopamine receptors of mammalian forebrain in vitroEuropean Journal of Pharmacology, 1980
- On the ability of N-chloroethyl aporphine derivatives to cause irreversible inhibition of dopamine receptor mechanismsJournal of Pharmacy and Pharmacology, 1980
- Phenoxybenzamine discriminates multiple dopamine receptorsEuropean Journal of Pharmacology, 1980
- (−)N-(Chloroethyl)norapomorphine inhibits striatal dopamine function via irreversible receptor bindingNature, 1980
- Inhibition of dopamine-stimulated adenylate cyclase activity by phenoxybenzamineEuropean Journal of Pharmacology, 1978